Table 3.
Multivariate survival analysis for disease-free and overall survival of the 42 patients
Disease-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
Variable | Hazard ratio | 95% confidence interval | P | Hazard ratio | 95% confidence interval | P |
Gender (male vs female ) | 0.448 | 0.144–1.395 | 0.166 | 0.275 | 0.069–1.100 | 0.068 |
Age (≥50 vs <50) | 1.058 | 0.249–4.507 | 0.939 | 0.777 | 0.134–4.491 | 0.778 |
Resection (yes vs no) | 0.782 | 0.113–5.429 | 0.804 | 1.937 | 0.219–17.092 | 0.552 |
Adjuvant treatment (yes vs no) | 1.385 | 0.421–4.555 | 0.591 | 2.853 | 0.649–12.545 | 0.165 |
Tumor size (>7 cm vs ≤7 cm) | 3.079 | 0.657–14.417 | 0.153 | 2.514 | 0.371–17.041 | 0.345 |
Myasthenia gravis (yes vs no) | 1.204 | 0.182–7.945 | 0.847 | 0.598 | 0.046–7.813 | 0.695 |
Stage (III + IV vs I + II ) | 6.163 | 2.421–15.691 | 0.000 | 5.462 | 1.923–15.514 | 0.001 |